DIDO-2 (aka Chen Jiayong 1, COSPAR 2017-008BE) is a nano-satellite of the Israeli/Swiss company SpacePharma. The nano-satellite is part of a research project whose goal is to test a miniaturized end-to-end pharmaceutical laboratory (called mGnify lab) in space under microgravity conditions. The project includes two satellites called DIDO-1 and DIDO-2. The platforms of the 3U CubeSats are developed and built by the Dutch company ISIS.
The first satellite DIDO-1 was originally to fly on a Falcon 9 in 2016. The current (as of 2019) status and plans for this satellite are unknown.
Launches are separated by dashes ( – ), payloads by dots ( · ), multiple names for the same satellite by slashes ( / ). CubeSats are smaller. Crewed flights are bolded. Launch failures are in italics. Payloads deployed from other spacecraft are (enclosed in brackets).